스마트 필 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Smart Pill Market size is expected to reach USD 7.37 Billion in 2034 from USD 2.66 Billion (2025) growing at a CAGR of 11.97% during 2026-2034.

The global smart pill market is gaining momentum as digital healthcare technologies continue to advance. Smart pills are ingestible electronic devices that can monitor internal health conditions, capture images of the gastrointestinal tract, and transmit data to healthcare providers. These devices are increasingly used for diagnostic purposes, particularly in gastrointestinal disorders, offering a less invasive alternative to traditional medical procedures.

Several factors are driving the growth of the smart pill market. Increasing prevalence of digestive diseases and the rising demand for minimally invasive diagnostic techniques are key contributors. Technological advancements in miniaturized sensors, wireless communication systems, and medical imaging technologies are improving the functionality and accuracy of smart pills. In addition, growing interest in remote patient monitoring and digital health solutions is encouraging healthcare providers to adopt these innovative diagnostic tools.

The future prospects of the smart pill market appear highly promising as healthcare systems increasingly adopt digital and connected medical technologies. Ongoing research and development efforts are focused on enhancing the capabilities of ingestible sensors, including drug delivery monitoring and real-time health tracking. As healthcare providers seek more efficient diagnostic solutions, smart pills are expected to play an increasingly important role in modern medical practice.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• Capsule Endoscopy
• Drug Delivery
• Vital Sign Monitoring

By Disease Identification

• Occult GI Bleeding
• Crohn's Disease
• Small Bowel Tumors
• Celiac Disease
• Inherited Polyposis Syndromes
• Neurological Disorders
• Others

By Target Area

• Esophagus
• Small Intestine
• Large Intestine
• Stomach

By End-use

• Hospitals
• Outpatient Facilities

COMPANIES PROFILED

• Medtronic, Otsuka Holdings Co Ltd, Olympus Corporation, CapsoCam Plus, Pentax Medical, JINSHAN Science Technology Group Co Ltd, CheckCap Ltd, etectRx, Intromedic, Shenzen Jifu Medical Technology Co Ltd, BodyCapUSA
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SMART PILL MARKET: BY APPLICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Capsule Endoscopy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Drug Delivery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Vital Sign Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SMART PILL MARKET: BY DISEASE IDENTIFICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Disease Identification
• 5.2. Occult GI Bleeding Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Crohn's Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Small Bowel Tumors Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Celiac Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Inherited Polyposis Syndromes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Neurological Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SMART PILL MARKET: BY TARGET AREA 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Target Area
• 6.2. Esophagus Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Small Intestine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Large Intestine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Stomach Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SMART PILL MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Outpatient Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SMART PILL MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Application
  • 8.2.2 By Disease Identification
  • 8.2.3 By Target Area
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Application
  • 8.3.2 By Disease Identification
  • 8.3.3 By Target Area
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Application
  • 8.4.2 By Disease Identification
  • 8.4.3 By Target Area
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Application
  • 8.5.2 By Disease Identification
  • 8.5.3 By Target Area
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Application
  • 8.6.2 By Disease Identification
  • 8.6.3 By Target Area
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL SMART PILL INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Medtronic
  • 10.2.2 Otsuka Holdings Co. Ltd
  • 10.2.3 Olympus Corporation
  • 10.2.4 CapsoCam Plus
  • 10.2.5 Pentax Medical
  • 10.2.6 JINSHAN Science & Technology (Group) Co. Ltd
  • 10.2.7 Check-Cap Ltd
  • 10.2.8 EtectRx
  • 10.2.9 Intromedic
  • 10.2.10 Shenzen Jifu Medical Technology Co. Ltd
  • 10.2.11 BodyCapUSA